What one share of DBV Technologies S.A. holds
DBV Technologies is a late-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT, our proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch).
DBV Technologies S.A.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$0.60 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.59 |
| Cash and investments | $0.59 |
| Book value | $0.54 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $0.40 | −$4.65 | $0.15 | −$4.16 | — | $4.11 |
| 2020 | $0.21 | −$2.95 | $0.05 | −$3.11 | — | $3.80 |
| 2021 | $0.10 | −$1.78 | $0.02 | −$1.99 | — | $1.80 |
| 2022 | $0.06 | −$1.24 | $0.01 | −$0.73 | — | $2.07 |
| 2023 | $0.17 | −$0.76 | $0.01 | −$0.84 | — | $1.46 |
| 2024 | $0.04 | −$1.17 | $0.02 | −$1.10 | — | $0.27 |
| 2025 | $0.04 | −$1.05 | $0.00 | −$0.87 | — | $0.57 |
Common questions about DBV Technologies S.A.
How much does one share of DBV Technologies S.A. earn?
Over the last 12 months, DBV Technologies S.A. lost $0.60 for each share on $0.02 of sales.
Does DBV Technologies S.A. pay a dividend?
DBV Technologies S.A. didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is DBV Technologies S.A.’s book value per share?
DBV Technologies S.A.’s book value is $0.54 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of DBV Technologies S.A. have?
Each share of DBV Technologies S.A. has $0.59 of cash and investments, as of June 30, 2026.
What is DBV Technologies S.A.’s free cash flow per share?
−$0.59 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has DBV Technologies S.A. bought back shares?
DBV Technologies S.A.’s share count rose about 277% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.